GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Integrated Diagnostics Holdings PLC (OTCPK:IDGXF) » Definitions » Total Equity

IDGXF (Integrated Diagnostics Holdings) Total Equity : $74.45 Mil (As of Jun. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Integrated Diagnostics Holdings Total Equity?

Integrated Diagnostics Holdings's total equity for the quarter that ended in Jun. 2024 was $74.45 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Integrated Diagnostics Holdings Total Equity Historical Data

The historical data trend for Integrated Diagnostics Holdings's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integrated Diagnostics Holdings Total Equity Chart

Integrated Diagnostics Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 146.78 154.60 177.87 99.33 100.31

Integrated Diagnostics Holdings Quarterly Data
Jun18 Dec18 Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23 Mar24 Jun24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 92.23 92.34 100.31 75.64 74.45

Integrated Diagnostics Holdings Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Integrated Diagnostics Holdings's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=186.675-86.362
=100.31

Integrated Diagnostics Holdings's Total Equity for the quarter that ended in Jun. 2024 is calculated as

Total Equity=Total Assets(Q: Jun. 2024 )-Total Liabilities(Q: Jun. 2024 )
=141.888-67.434
=74.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integrated Diagnostics Holdings Total Equity Related Terms

Thank you for viewing the detailed overview of Integrated Diagnostics Holdings's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Integrated Diagnostics Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Integrated Diagnostics Holdings PLC (OTCPK:IDGXF) » Definitions » Total Equity
Comparable Companies
LSE:DXRX LSE:AGL LSE:LLAI LSE:PRM LSE:ABDX LSE:VRCI LSE:GDR LSE:GENI TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN LH DGX
Traded in Other Exchanges
IDHCl:UK IDHC:UK
Address
IFC 5, Saint Helier, JEY, JE1 1ST
Website
https://www.idhcorp.com
Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider, operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan, Echo-Lab in Nigeria; and Biolab KSA in Saudi Arabia. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segments, Contract Segment which generates key revenue, and the Walk-in Segment. It derives a majority of its revenue from services offered in Egypt.